• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Thromb J . The evolution of clot strength in critically ill COVID-19 patients: a prospective observational thromboelastography study

tetano

Editor, Senior Moderator
Thromb J


. 2022 Feb 14;20(1):8.
doi: 10.1186/s12959-022-00365-3.
The evolution of clot strength in critically ill COVID-19 patients: a prospective observational thromboelastography study


Syed Nabeel Muzaffar[SUP] 1 [/SUP], Suhail Sarwar Siddiqui[SUP] 2 [/SUP], Nilanchal Chakraborty[SUP] 3 [/SUP], Afzal Azim[SUP] 4 [/SUP]



Affiliations

Abstract

The authors have done commendable work in exploring the utility of a comprehensive viscoelastic test for assessment of the coagulation cascade in Coronavirus disease 2019 (COVID-19) patients. This article published in your esteemed journal in November 2021 "The evolution of clot strength in critically-ill COVID-19 patients: a prospective observational thromboelastography study" found hypercoagulability in most of the patients at Intensive Care Unit (ICU) admission and also noted a persistently increased fibrin contribution to clot strength. However, we would like to comment upon a few points which may be of importance to the readers.

Keywords: COVID-19; Hypercoagulability; Thromboelastography (TEG); fibrinolysis.
 
Back
Top Bottom